Centese
OMAHA, NE · Health Care · 15 employees
Centese is a medical technology company focused on advancing post-operative care through innovative wound management solutions. Their flagship product, Thoraguard, is the first and only FDA-cleared intelligent chest drainage system designed to enhance patient outcomes following cardiothoracic surgery. By integrating smart sensing technology and real-time data analytics, Centese helps clinicians ma
Funding history
- Funding Round — $250K — May 2026
- Series seed — $525K — May 2025
- Funding Round — $15.1M — Nov 2023
Recent signals
- May 26, 2026: Raised $250K
- May 12, 2025: Raised $525K in Series seed
- Nov 20, 2023: Raised $15.1M
See plans & pricing → Track Centese’s funding, hiring, and signals — with verified contacts — on Fundz.